Parallel remission of nonsteroidal anti-inflammatory drugs-exacerbated cutaneous reactions and chronic spontaneous urticaria
-
Published:2024-08
Issue:8
Volume:12
Page:2208-2210
-
ISSN:2213-2198
-
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
-
language:en
-
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice
Author:
Sánchez JorgeORCID,
Diez Susana,
Lopez Juan-Felipe
Funder
Universidad de Antioquia
Reference9 articles.
1. The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria;Zuberbier;Allergy,2022
2. Aspirin-exacerbated cutaneous disease (AECD) is a distinct subphenotype of chronic spontaneous urticaria;Sánchez-Borges;J Eur Acad Dermatol Venereol,2015
3. Prospective analysis of clinical evolution in chronic urticaria: persistence, remission, recurrence, and pruritus alone;Sánchez;World Allergy Organ J,2022
4. Children with chronic spontaneous urticaria: recurrence after remission and its predictors;Özyılmaz-Bozat;J Allergy Clin Immunol Pract,2020
5. Is H1-antihistamine (desloratadine 5 mg, orodispersible tablet) premedication in NSAID-associated urticaria really safe and practicable in “real life”;Liccardi;J Allergy Clin Immunol Pract,2017